by admin | Nov 8, 2023 | Newsletter
November 2023 Past Newsletters Healthspan–Vol. 12 Healthspan-Vol. 11 Healthspan–Vol. 10 Healthspan– Vol. 9 Healthspan-Vol. 8 Healthspan–Vol. 7 All Newsletters Welcome to our newsletter Our Coalition seeks to unite all stakeholders who have an interest in...
by admin | Nov 7, 2023 | news articles
By Neuroscience News.com Using the American Heart Association’s Life’s Essential 8 checklist against phenotypic age—a measure based on blood markers rather than chronological age—researchers found a clear correlation: better heart health was linked with younger...
by admin | Nov 6, 2023 | news articles
Mayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive dementia (RPD) with reasonably high confidence during a patient’s first clinical visit. This scoring criteria may allow physicians...
by admin | Nov 4, 2023 | news articles
by Arkadi Mazin – Lifespan.io The need for a paradigm shift Last August, hundreds of longevity enthusiasts, from certified geroscience stars to graduate students, gathered in Dublin for the annual Longevity Summit conference. As the attendants were enjoying the...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/U5VZBBJ5SBJARD5TTCJHHDF6VM.jpg "FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study")
by admin | Nov 3, 2023 | news articles
By Reuters News Oct 31 (Reuters) – A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN) could assess potential safety risks of their sickle cell disease gene therapy after approval. If...
